In response to COVID-19, Mzbio, Inc. and its labs are working on faster and more accurate PCR methods to diagnose the virus. By sharing ideas and collaborating with Harvard University and local hospitals, we hope to make greater progress together.
A simple work-flow platform for DNA absolute quantification that supports clinical diagnostics, drug development, and life science research. We work on fundamental technology innovations that make precision medicine accessible to everyone.
Core Product Line
Mzbio digital PCR M-1000 series
Fully automated and integrated
Desktop or portable device
Mzbio digital PCR analysis kit (MobiChips and reagents)
Massachusetts General Hospital
Brigham and Women’s Hospital